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Microalgae are currently used for the production of food compounds. Recently, few
microalgae species have been investigated as potential biofactories for the production
of biopharmaceuticals. Indeed in this context, microalgae are cheap, classified as
Generally Recognized As Safe (GRAS) organisms and can be grown easily. However,
problems remain to be solved before any industrial production of microalgae-made
biopharmaceuticals. Among them, post-translational modifications of the proteins need to
be considered. Especially, N-glycosylation acquired by the secreted recombinant proteins
is of major concern since most of the biopharmaceuticals are N-glycosylated and it is well
recognized that glycosylation represent one of their critical quality attribute. Therefore,
the evaluation of microalgae as alternative cell factory for biopharmaceutical productions
thus requires to investigate their N-glycosylation capability in order to determine to what
extend it differs from their human counterpart and to determine appropriate strategies for
remodeling the microalgae glycosylation into human-compatible oligosaccharides. Here,
we review the secreted recombinant proteins which have been successfully produced
in microalgae. We also report on recent bioinformatics and biochemical data concerning
the structure of glycans N-linked to proteins from various microalgae phyla and comment
the consequences on the glycan engineering strategies that may be necessary to render
those microalgae-made biopharmaceuticals compatible with human therapy.
Keywords: microalgae, biopharmaceuticals, glycosylation pathway, glycan, Chlamydomonas reinhardtii ,
Phaeodactylum tricornutum, endoplasmic reticulum, Golgi apparatus
INTRODUCTION
Nowadays, biopharmaceuticals on the market consists of 200
products yielding overall global revenue greater than US$100
billion (Walsh, 2010). Over the past 5 years, 140 biopharma-
ceuticals were approved in the European Union (EU) and the
United States (US) markets (Walsh, 2010). These biopharma-
ceuticals are produced in various systems ranging from bac-
teria to mammalian cell cultures (Wong, 2005; Demain and
Vaishnav, 2009; Huang et al., 2012). Among those, the Chinese
Hamster Ovary (CHO) cells are currently the predominant
industrial cell lines used for producing those drugs (Hossler
et al., 2009), covering about 50% of the market (Demain and
Vaishnav, 2009). However, the constant increasing needs for
large amount of such therapeutic proteins, their high produc-
tion cost in conventional expression systems and complicating
factors related to potential virus contamination have driven sci-
entists to explore new alternative production systems. In this
context, various plant expression systems have emerged, includ-
ing whole plants (Nicotiana, Alfalfa, Maize for examples) and
in vitro culture systems such as plant cell suspensions (Nicotiana
tabaccum, Lemna minor, Physcomitrella patens) and hairy roots
(Stoger et al., 2005; Drake et al., 2009; Colgan et al., 2010;
Decker and Reski, 2012; Parsons et al., 2012; Xu et al., 2012;
Schillberg et al., 2013; Twyman et al., 2013; Buyel and Fischer,
2014). Several plant-made biopharmaceuticals have been suc-
cessfully produced (De Muynck et al., 2010). This includes the
Cerezyme’s biosimilar (glucocerebrosidase) which has been pro-
duced in carrot cells (Shaaltiel et al., 2007) and was approved on
May 2012 by the US Food and Drug Administration (Maxmen,
2012). Despite those successes, there is an increasing interest to
use microalgae for biopharmaceutical production. Microalgae are
unicellular photosynthetic organisms which encompass between
40,000 and probably several billion species (Cadoret and Bernard,
2008; Mata et al., 2010). As plants, microalgae are classified in
Generally Recognized As Safe (GRAS) organisms. Moreover, they
are cheap and easy to grow, making them potentially attrac-
tive cell factories for the large-scale production of recombinant
proteins.
To date, microalgae have been mainly used for the pro-
duction of food compounds or high-value added compounds
like carotenoids (Spolaore et al., 2006; Sasso et al., 2012).
In addition, as photosynthetic organisms, microalgae are very
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efficient in converting sunlight into chemical energy, making
them attractive for the production of carbohydrates, lipids, and
hydrogen. Therefore, algal biomass represents a great poten-
tial for generating new sources of bioenergy such as biofuels
(Beer et al., 2009; Lam and Lee, 2012; Merchant et al., 2012)
and biomaterials (Hempel et al., 2011a). Several microalgae
species have also been evaluated for their potential to express
recombinant proteins. Among them, the model Chlorophyceae
Chlamydomonas reinhardtii is currently the most investigated one
for such a biotechnological application, due to the availability
of genomic data and the existence of a powerful molecular
toolkit including vectors allowing nuclear or chloroplastic trans-
formation (Merchant et al., 2007; Harris, 2009). Additionally,
the diatom Phaeodactylum tricornutum is also considered as an
emerging system for such an application (Hempel et al., 2011b;
Hempel and Maier, 2012) as it can be genetically modified and
grown quite easily. Other species are also good candidates for
large-scale production of recombinant proteins, especially due
to their ease to obtain algal biomass and their growth rate.
For example, a marine green microalga from the class of the
Chlorophyceae, Dunaliella salina (Geng et al., 2003), but also
species from the genus Chlorella [i.e., Chlorella vulgaris, recently
renamed Coccomyxa sp. C-169 subellipsoidea (Blanc et al., 2010),
Chlorella ellipsoidea], which belongs to the Trebouxiophyceae,
are promising bio-factories for large-scale production of high-
value added proteins (Hawkins and Nakamura, 1999; Chen et al.,
2001; Kim et al., 2002; Bai et al., 2013). However, molecular
biology tools remain poorly developed for most of those microal-
gae even if genomic data became available (http://genome.
jgi.doe.gov/; http://www.phytozome.net/; http://www.ncbi.nlm.
nih.gov/genome).
Whatever the considered species, many problems have
still to be solved before any industrial production and
commercialization of microalgae-made biopharmaceuticals.
Among them, increasing the yield and secretion of recombinant
protein represents a crucial issue to make these organisms com-
petitive with traditionally used expression systems such as the
CHO cell lines. Furthermore, post-translational modifications
need to be considered. Especially,N-glycosylation acquired by the
secreted recombinant proteins is crucial for biopharmaceuticals
since more than one third of the approved ones are glycosylated
(Gomord et al., 2010) and it represents a critical quality attribute
for them (Lingg et al., 2012). Indeed, the presence and structures
of the N-glycans are required for their biological activity, stability
and half-life (Lingg et al., 2012). The evaluation of microalgae
as alternative cell factory for biopharmaceutical production thus
requires investigating their N-glycosylation capability in order
to determine to what extend their N-glycans differ from their
human counterpart. In this paper, we report on bio-informatic
and biochemical data concerning the structures of glycan N-
linked to endogenous proteins from various microalgae phyla.
Based on these recent findings, strategies for the engineering
of the glycosylation pathways in these new expression systems
are proposed to obtain microalgae-made biopharmaceuticals
that would carry oligosaccharides compatibles with human
therapies.
MICROALGAE AS ALTERNATIVE SYSTEMS FOR
PRODUCTION OF RECOMBINANT PROTEINS
AVAILABLE TOOLS FOR NUCLEAR TRANSFORMATION IN MICROALGAE
Chlamydomonas reinhardtii
Currently, most of the studies reporting the expression of recom-
binant proteins in microalgae have been performed in the green
alga Chlamydomonas reinhardtii. The majority of such pro-
ductions has been targeted to the chloroplast. This concerned
biopharmaceuticals such as the single-chain antibody directed
against the glycoprotein D of the herpes simplex virus (Mayfield
et al., 2003), but also the heavy and light chains of the antibody
83K7C, derived from a human IgG1 (Tran et al., 2009), human
erythropoietin, domains 10 and 14 of human fibronectin, inter-
feron β1, proinsulin, vascular endothelial growth factor (VEGF),
high mobility group protein B1(HMGB1) (Rasala et al., 2010)
and two different immunotoxin proteins (Tran et al., 2012).
Recently, an attenuated form of the E7 oncoprotein of the human
papillomavirus (HPV) has also been produced in the same
organelle (Demurtas et al., 2013). Indeed, this strategy is the most
promising one to get high protein yields since C. reinhardtii pos-
sesses a large single chloroplast, representing about 40% of the
total cell volume, and the proteins expressed in this organelle
have been shown to represent 2–20% of total soluble proteins
(Rasala and Mayfield, 2011). Moreover, three proteins have been
shown to be expressed at levels which are sufficient for com-
mercial production (Rasala et al., 2010). In contrast, secreted
proteins produced from nuclear transformation in C. reinhardtii
generally failed to accumulate to an equivalent level as the one
observed in chloroplasts (Fuhrmann et al., 1999; Schroda et al.,
2000; Specht et al., 2010). The low proteolysis in chloroplast
could explain the high yields of recombinant proteins reached
in this organelle (Surzycki et al., 2009; Potvin and Zhang, 2010).
However, as far as glycosylated proteins such as biopharmaceu-
ticals are concerned, chloroplast lacks the enzymatic machinery
required for N-glycosylation. Therefore, for biopharmaceuti-
cal production, both nuclear expression and protein transport
through the secretory pathway of microalgae are required.
Despite recent progress, nuclear expression remains challeng-
ing in C. reinhardtii (Specht et al., 2010). Indeed, low levels of
expression usually observed could result from transgene silencing
(Cerutti et al., 1997; Shaver et al., 2010; Rasala et al., 2012). Its
GC-rich genome (Merchant et al., 2007) has been also thought to
be a hindrance to the expression of foreign genes since it intro-
duces a codon usage bias. Several strategies have been developed
during the last decade to circumvent these problems. Among
them, the necessity to optimize the coding sequence of the gene of
interest appears to be essential for improving the nuclear expres-
sion of the foreign protein (Fuhrmann et al., 1999). With regards
to promoter sequences, a few assays have been performed to
express reporter genes under the control of the plant constitu-
tive CaMV35S promoter (Ruecker et al., 2008; Díaz-Santos et al.,
2013) or of other viral sequences (Ruecker et al., 2008). Recently,
a high light-inducible promoter from Dunaliella has also been
investigated in C. reinhardtii. This promoter has been shown to
drive efficiently the expression of the luciferase reporter gene but
it has not been used for expression of any biopharmaceutical yet
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(Park et al., 2013). Currently, the major part of nuclear trans-
genes are expressed through a hybrid promoter, resulting from
the fusion of the photosystem I complex (PSAD) (Fischer and
Rochaix, 2001) or the Ribulose Bisphosphate Carboxylase Small
Subunit (RBCS2) (Kindle, 1998) promoters with the HSP70A
promoter which allows increasing the expression of the transgene
(Schroda et al., 2000). In addition, several regulatory sequences
have been included in the transgene coding sequence to enhance
its expression. Thus, the insertion of the first intron of RBCS2
(Lumbreras et al., 1998), but also of the second and third introns
(Eichler-Stahlberg et al., 2009) are required to increase the efficacy
of the HSP70A/RBCS2 promoter. Compared to the CaMV35S
promoter, these chimeric promoters remain actually the most
efficient to drive the constitutive expression of nuclear trans-
genes in C. reinhardtii (Ruecker et al., 2008; Eichler-Stahlberg
et al., 2009; Neupert et al., 2009; Rasala et al., 2012; Kumar
et al., 2013). However, with a yield of secreted EPO estimated
to 0.1mg per liter of culture medium (Eichler-Stahlberg et al.,
2009), the expression level of EPO under the control of the
HSP70A/RBCS2A promoter remains too low for large scale
production.
Rasala et al. (2012) developed a new vector in which the gene
of interest is fused to the BLE gene of selection (which confers the
resistance to bleomycin) via the nucleotide sequence encoding the
foot-and-mouth-disease-virus 2A self-cleavage peptide (FMDV
2A) under the control of the HSP70A/RBCS2 promoter. The
resulting translated product is processed into two proteins, with
the 2A peptide fused to the C-terminal end of the first protein
as already described for other expressions using a 2A self-cleavage
peptide (Ho et al., 2013). This tandem expression allows the selec-
tion of transformants exhibiting a higher transgene expression.
Finally, Neupert et al. (2009) used UV mutagenesis to generate
new C. reinhardtii strains presenting the advantage to increase
the expression of nuclear transgenes. Indeed, using one of these
strains (UVM4) transformed with the specific vector pcCAgLUC
allowing the expression of the luciferase protein fused to the pre-
dicted signal peptide of the extracellular carbonic anhydrase 1
(CAH1), Lauersen and coworkers demonstrated that the amount
of secreted recombinant proteins could be significantly improved,
reaching up to 10mg per liter of culture (Lauersen et al., 2013a).
However, despite these significant achievements, efforts are still
necessary to make C. reinhardtii competitive with CHO cell lines,
for which yield between 5 and 10 g/L of recombinant protein is
currently obtained (Demain and Vaishnav, 2009).
Other microalgae
Recently, other microalgae species have also been shown to be
of interest as new expression systems. For example, two recent
studies reported the expression of a monoclonal human IgG anti-
body against the Hepatitis B and its respective antigen in the
diatom P. tricornutum. This antibody was either secreted in the
culture medium or expressed in fusion to a DDEL (instead of
KDEL which is used as a standard ER retention signal in other
eukaryotes) sequence allowing its retention within the endoplas-
mic reticulum (ER) of Phaeodactylum tricornutum (Hempel et al.,
2011b; Hempel and Maier, 2012). In contrast to C. reinhardtii,
the codon usage in P. tricornutum is much closer to that of
human (Heitzer et al., 2007), which could give advantage to this
diatom for the production of biopharmaceuticals. In P. tricornu-
tum, nuclear expression of transgenes is usually mediated through
the promoter of the FCPA gene which encodes the fucoxanthin
chlorophyll a/c binding protein (Apt et al., 1996; Zaslavskaia et al.,
2000) or through the nitrate reductase promoter which is induced
when ammonium is replaced by nitrates as nitrogen source in
the culture medium (Poulsen and Kröger, 2005; Gonzalez et al.,
2011; Hempel et al., 2011b; Hempel and Maier, 2012; Stork
et al., 2012). This specific nitrate reductase inducible promoter
was used to express the fully-assembled human IgG antibody
against Hepatitis B leading to 1.5–2.5mg of recombinant anti-
body per liter of culturemedium depending of the different clones
(Hempel andMaier, 2012) and 21mg per gram of algal dry weight
for the ER-retained form of the antibody (Hempel et al., 2011b).
Expression of commercially relevant proteins in other species
of microalgae remains less reported, since tools for nuclear trans-
formation are still missing. As for C. reinhardtii, the CaMV35S
promoter has been shown to be efficient in several other green
microalgae, including C. ellipsoidea (Jarvis and Brown, 1991;
Chen et al., 2001; Kim et al., 2002), C. vulgaris (Hawkins and
Nakamura, 1999), Haematococcus pluvialis (Kathiresan et al.,
2009) and D. salina (Geng et al., 2003; Feng et al., 2009; Chai
et al., 2013) but in most of the cases, the expression levels
achieved remained low. Some studies reported the use of other
foreign promoters to drive the nuclear expression of heterologous
proteins in Chlorella sp., such as the C. reinhardtii RBCS2 pro-
moter which has been used successfully in Chlorella ellipsoidea
for transient expression of recombinant protein or resistance
expression (Hawkins and Nakamura, 1999; Kim et al., 2002). In
contrast, the ubiquitin maize promoter seems to be promising in
Chlorella sp., since it allows the stable expression of a rabbit gene
encoding for an α-defensin (Bai et al., 2013). In some cases, the
omega element of Tobacco Mosaic Virus (TMV) which is part of
the 5′UTR has been used to enhance translation efficiency (Chen
et al., 2001), leading to a yield of about 11mg/L of recombinant
protein (Bai et al., 2013). This ubiquitin- promoter was also suc-
cessfully used in D. salina to stably express a gene encoding the
hepatitis B surface antigen (Geng et al., 2003).
EXPRESSION OF SECRETED THERAPEUTIC RECOMBINANT PROTEINS
IN MICROALGAE
As mentioned previously, most of the recombinant proteins that
have been produced in C. reinhardtii so far were expressed in
the chloroplast because of the high level of protein accumulation
reached in this organelle. Thus, among the 20 recombinant pro-
teins of industrial interest expressed in C. reinhardtii (for a recent
review, see Rasala and Mayfield, 2014), only 3 of them have been
expressed successfully through the nuclear genome: a xylanase
(Rasala et al., 2012), an ice binding-protein (Lauersen et al.,
2013b) and the secreted EPO (Eichler-Stahlberg et al., 2009).
As the xylanase and ice binding-protein are not therapeutical
proteins, we will not discuss them further in this review. In addi-
tion, by using the signal peptide of the C. reinhardtii gene ARS2
encoding a periplasmic arylsulfatase, the EPO has been produced
in the culture medium of C. reinhardtii (Eichler-Stahlberg et al.,
2009;Table 1). Furthermore, as previously indicated, Hempel and
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Table 1 | Post-translational modifications of biopharmaceuticals expressed in the secretory system of microalgae.
Expressed protein Promoter N-glycosylation sitea Glycosylationb References
IN C. REINHARDTII
Human EPO Hsp70A/RbcS2 Yes Yes Eichler-Stahlberg et al., 2009
IN P. TRICORNUTUM
Monoclonal human IgG against
the Hepatitis B surface antigen
Nitrate reductase Yes Yes Hempel et al., 2011b; Hempel
and Maier, 2012
Hepatitis B surface antigen Nitrate reductase Yes No Hempel et al., 2011b
IN D. SALINA
Hepatitis B surface antigen Maize Ubiquitin + TMV enhancer Yes No Geng et al., 2003
aPredicted N-glycosylation sites by bio-informatic analysis of the protein sequence.
bExperimental evidence of the presence of N-glycans attached to the N-glycosylation site.
Maier (2012) demonstrated the capability of P. tricornutum to
synthesize and secrete a full length functional human IgG anti-
body against the Hepatitis B virus surface antigen. This study
clearly demonstrates that diatoms are able to produce and cor-
rectly assemble complex proteins without affecting their biologi-
cal activity (Table 1).
Little information is available on the post-translational modi-
fications acquired by these microalgae-made therapeutic proteins
in the secretory pathway. For example, the recombinant EPO
expressed in C. reinhardtii exhibited a molecular mass of about
33 kDa suggesting the presence of post-translational modifica-
tions such as the addition of glycans on the microalgae-made
EPO. This is consistent with the fact that the EPO is known to
possess 3 N-glycosylation and one O-glycosylation sites (Table 1)
(Lingg et al., 2012). Moreover, affinoblotting with concanavalin
A, a lectin specific for oligomannoside structures (Fitchette et al.,
2007), of the ER-resident recombinant IgG expressed in P. tri-
cornutum also suggested that this microalgae-made antibody
is glycosylated (Table 1) (Hempel et al., 2011b). However, no
structural detailed analyses are reported regarding the glycans
attached to those microalgae-made biopharmaceuticals. Since the
N-glycosylation of biopharmaceuticals is critical for their half-
life, stability and biological activity (for a recent review, see
Lingg et al., 2012), it is therefore essential to characterize the
N-glycosylation process of secreted protein in microalgae.
N-GLYCOSYLATION PATHWAYS IN MICROALGAE
GENERAL ASPECTS OF N-GLYCOSYLATION IN EUKARYOTES
N-glycosylation is a major co- and post-translational modifica-
tion of proteins in eukaryotes occurring in both the ER and
the Golgi apparatus (Figure 1). In this process, a lipid-linked
oligosaccharide is first assembled by the stepwise addition of
monosaccharides on a dolichol pyrophosphate on the cytoso-
lic face and then in the lumen of the ER (Burda and Aebi,
1999). This precursor is then transferred by the oligosaccha-
ryltransferase (OST) complex onto the asparagine residues of
the consensus Asn-X-Ser/Thr sequences of a protein (Burda and
Aebi, 1999). In 3.5% of the cases, other sequences like Asn-X-
Cys, Asn-X-Val have been proven to be glycosylated on endoge-
nous or recombinant protein produced both in mammals or
plant cells (Gil et al., 2009; Zielinska et al., 2010; Matsui et al.,
2011). The precursor is deglucosylated by the α-glucosidases I
and II and then reglucosylated by an UDP-glucose: glycopro-
tein glucosyltransferase (UGGT) to ensure the proper folding
of the nascent protein through its interaction with ER-resident
chaperones, such as calnexin and calreticulin. These ER events
are conserved in eukaryotes because they are crucial for efficient
protein folding and oligomerization (Helenius and Aebi, 2001).
In contrast, evolutionary adaptation of N-glycan processing in
the Golgi apparatus has given rise to a variety of organism-
specific complex structures (Varki, 2011). First, α-mannosidases
degrade the oligosaccharide precursor into oligomannosides
ranging fromMan9GlcNAc2 toMan5GlcNAc2 (Man-9 toMan-5).
N-acetylglucosaminyltransferase I (GnT I) then transfers a first
N-acetylglucosaminyl (GlcNAc) residue on Man-5 and initiates
the synthesis of a large variety of structurally different complex-
type N-glycans. In this GnT I-dependent N-glycan maturation,
the processing continues by the removal of twomannosyl residues
and the transfer of a second terminal GlcNAc residue, thus result-
ing in the synthesis of a core GlcNAc2Man3GlcNAc2 which are
common to mammals and all land plants studied so far (Lerouge
et al., 1998; Wilson et al., 2001; Gomord et al., 2010; Varki,
2011) (Figure 1). This core is then decorated by the action of
a specific repertoire of glycosyltransferases that differ from one
organism to another. As a consequence, mature proteins leaving
the secretory pathway carry organism-specific complexN-glycans
allowing the protein to acquire a set of glycan-mediated biological
functions (Varki, 1993; Gagneux and Varki, 1999). For instance,
in mammals, most secreted proteins in blood circulation carry
biantennaryN-glycans decorated with α(1,6)-fucose residues and
terminal sialic acids that impact either the protein activity or
protein half-life (Figure 1; Lingg et al., 2012). In contrast, plant
N-glycans are mainly of biantennary complex type N-glycan car-
rying a core-β(1,2)–xylose; a core α(1,3)-fucose and eventually
terminal Lewis a antennae (Lerouge et al., 1998; Wilson et al.,
2001).
By comparison with data available in pluricellular eukaryotes,
information concerning protein N-glycosylation in microalgae
remains very limited. A few studies using lectin blot analysis or
enzymatic sequencing suggested that proteins secreted by green
microalgae carry mainly oligomannosides or complex N-glycans
having a core xylose residue (Balshüsemann and Jaenicke, 1990;
Grunow et al., 1993; Gödel et al., 2000). More recently, a cell
wall glycoprotein from the red microalgae Porphyridium sp. was
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FIGURE 1 | Mammalian N-glycosylation pathway. This pathway starts in
the endoplasmic reticulum (ER) and ends in the Golgi apparatus where the
major maturation steps lead to sialylated and fucosylated biantennary
protein N-linked glycans. The N-glycan structures presented here are
annotated according to the symbolic nomenclature adopted by the
Consortium for Functional Glycomics (Varki et al., 2009). PP-Dol:
Pyrophosphate Dolichol; OST: oligosaccharyltransferase; Asn, asparagine;
UGGT, UDP-glucose glycoprotein glucosyltransferase; α-Man,
α-mannosidase; GnT, N-acetylglucosaminyltransferase; Man-8/9,
oligomannoside bearing 8/9 mannose residues; Man-5, oligomannoside
bearing 5 mannose residues. Mannose Glucose Galactose
Sialic acid Fucose N-acetylglucosamine.
found to carry Man-8 and Man-9 oligomannosides containing 6-
O-methyl mannoses and substituted by one or two xylose residues
(Levy-Ontman et al., 2011).
STRUCTURAL INVESTIGATION OF GLYCAN N-LINKED TO MICROALGAE
PROTEINS OF CHLAMYDOMONAS REINHARDTII AND
PHAEODACTYLUM TRICORNUTUM
Deeper insights into the structure of glycans N-linked to pro-
teins secreted by C. reinhardtii (Mathieu-Rivet et al., 2013) and
P. tricornutum (Baïet et al., 2011) have been recently reported
and N-glycosylation pathways in these two microalgae dedicated
to biotechnology applications have been proposed. These studies
combined data resulting from the search for genes encoding puta-
tive enzymes involved in the N-glycosylation pathway in the
genomic databases and data resulting from biochemical analysis
of glycan N-linked to secreted proteins.
Bio-informatic analysis
In C. reinhardtii and P. tricornutum genomes, most of the
genes encoding enzymes involved in the biosynthesis of the
dolichol pyrophosphate-linked oligosaccharide on the cytoso-
lic face and in the lumen of the ER, named Asparagine-Linked
Glycosylation (ALG) (Weerapana and Imperiali, 2006), are pre-
dicted (Figure 2). Although some ALG were not clearly identified
in the genomes, large oligomannosides up to Man-9 were found
in both C. reinhardtii (Mathieu-Rivet et al., 2013) and P. tricor-
nutum (Baïet et al., 2011) suggesting that the synthesis of the
oligosaccharide precursor is similar to the one described in other
eukaryotes. In addition to ALG, genes encoding subunits of the
oligosaccharyltransferase were also identified in both genomes
(Figure 2). Glucosidases I and II, as well as ER-resident UGGT
and chaperones such as calreticulin, are also predicted. These pro-
teins are key elements of the quality control of proteins occurring
in the ER and are crucial for acquisition of the proper folding of
the nascent glycoprotein (Figure 2).
After the transfer of the glycoprotein into the Golgi apparatus,
maturation ofN-linked glycans starts with the trimming of Man-
9/-8 by α-mannosidases I (α-Man I) that generate oligomanno-
sides ranging fromMan-8 to Man-5. Genes encoding α-Man I are
predicted in C. reinhardtii and P. tricornutum genomes (Figure 2)
suggesting that Golgi mediated trimming of oligommanosides
also occurs in both microalgae. In higher eukaryotes including
animals, insects and land plants, N-glycans are then processed
by GnT I that transfers a first N-acetylglucosaminyl (GlcNAc)
residue on the α(1,3)-mannose arm of Man-5 (Figure 1). Thus,
GnT I is a key enzyme since it is the first glycosyltransferase occur-
ring in the Golgi apparatus in the GnT I-dependent pathway
giving rise to complex N-glycans that are required for nor-
mal morphogenesis in pluricellular organisms (Ioffe and Stanley,
1994; Metzler et al., 1994). A sequence encoding for a GnT I
is predicted in P. tricornutum (Baïet et al., 2011) but not in C.
reinhardtii (Mathieu-Rivet et al., 2013) suggesting that N-linked
glycans from these twomicroalgae could be processed in the Golgi
apparatus according to two different pathways, referred to as GnT
I-dependent and GnT I-independent pathways (Zhu et al., 2004;
Crispin et al., 2006; Grass et al., 2011).
In both GnT I-dependent and independent pathways, the next
steps mainly consist in the transfer of monosaccharides on the
N-glycan core to synthesize highly diverse complex N-glycans.
Among residues that are added to the core, fucosyl residues either
α(1,3)- or α(1,6)-linked to the proximal GlcNAc are commonly
observed. In both microalgae, sequences encoding for putative
α(1,3)-fucosyltransferases were identified in the genomes (Baïet
et al., 2011; Mathieu-Rivet et al., 2013). Search for other genes
encoding for putative N-glycan processing enzymes revealed
sequences exhibiting homologies with α-Man II and GnT II in
P. tricornutum but functional characterizations remain necessary
to assess their enzymatic activities.
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FIGURE 2 | Comparison of the N-glycosylation pathways in
P. tricornutum and C. reinhardtii. In both microalgae, mature N-linked
glycans have been structurally characterized. Genomic data are in
agreement with the biochemical ones and are summarized in this figure.
Sequences predicted in both C. reinhardtii and P. tricornutum genomes are
written in bold. ALG10 in P. tricornutum genome and ALG3, 6 and 12 in
C. reinhardtii genome have not been identified yet. The N-glycan structures
presented in this figure are annotated according to the symbolic
nomenclature adopted by the Consortium for Functional Glycomics (Varki
et al., 2009). DPM1: Dolichol-phosphate mannosyltransferase; ALG:
Asparagine-Linked Glycosylation; PP-Dol: Pyrophosphate Dolichol; P-Dol:
Dolichol phosphate; OST: oligosaccharyltransferase; Asn, asparagine; UGGT,
UDP-glucose glycoprotein glucosyltransferase; GnT,
N-acetylglucosaminyltransferase; α-Man, α-Mannosidase; FuT,
Fucosyltransferase; XylT, xylosyltransferase; Man-9, oligomannoside
bearing 9 mannose residues; Man-5, oligomannoside bearing 5 mannose
residue; Man-2, N-glycans bearing 2 mannose residues. Mannose
Glucose Methyl mannose Fucose Xylose N-acetylglucosamine.
Biochemical analysis
A detailed glycomic analysis of C. reinhardtii proteins indicated
that both secreted and membrane-bound proteins carry oligom-
manosides ranging from Man-2 to Man-5 and also complex
N-glycans containing 6-O-methyl mannoses and substituted by
one or two xylose residues (Figure 2) (Mathieu-Rivet et al.,
2013). Similar complex structures have been previously found
in a cell wall glycoprotein isolated from the red microalgae
Porphyridium sp. (Levy-Ontman et al., 2011). However, the loca-
tion of the xylose residue on the core N-glycan differs in these
two microalgae, since it is described to be linked to the chito-
biose unit in Porphyridium rather than to C2 of the β-mannose
as described in C. reinhardtii and as previously reported in
land plants (Figure 2) (Lerouge et al., 1998). In agreement with
bio-informatics data suggesting the absence of GnT I, these com-
plex N-glycans are likely to result from the transfer of xylose
residues onto Man-5 oligomannosides in a GnT I-independent
manner. Then, methylation of mannose residues is thought to
occur after xylosylation of complex N-glycans in C. reinhardtii
as proposed in Figure 2. Alternatively, Man-5 can be trimmed
by mannosidases down to Man-2 (Figure 2). Although O-methyl
mannose residues was previously reported in some eukary-
otes (Staudacher, 2012), complex N-glycans from C. reinhardtii
highly differ from glycans described in animals and land plants.
We postulate that xylosylation and methylation of oligoman-
nosides in these microalgae may protect glycoproteins against
deglycosylating enzymes such as endoglycosidases or peptide
N-glycosidases.
In contrast to complex N-glycans from C. reinhardtii, gly-
cans N-linked to proteins secreted by the diatom P. tricornu-
tum can be processed through a GnT I-dependent pathway
into partially fucosylated Man-3 (Figure 2) (Baïet et al., 2011).
The GnT I gene predicted in the P. tricornutum genome was
demonstrated to encode an active enzyme able to restore the
maturation of N-linked glycans into complex-type N-glycans
in the CHO Lec1 mutant, defective in its endogenous GnT I
(Baïet et al., 2011). The authors have proposed that this fuco-
sylated N-linked glycan results from the addition of a termi-
nal GlcNAc residue by GnT I on Man-5 followed by removal
of two Man residues by an α-Man II and the transfer of a
fucose residue by the predicted α(1,3)-FuT (Baïet et al., 2011).
As illustrated in the proposed pathway depicted in Figure 2,
the terminal GlcNAc introduced in the Golgi apparatus by the
P. tricornutum GnT I is then likely removed in the secretory
pathway by glucosaminidases as previously described in land
plants and insect (Vitale and Chrispeels, 1984; Altmann et al.,
1995). Efficient complementation of the CHO Lec1 mutant is
the main argument supporting that this diatom processes its
N-glycans through a GnT I-dependent pathway. This result
also indicates that the microalgae transferase is properly tar-
geted to the Golgi apparatus when expressed in mammalian
cells.
In these two studies performed on P. tricornutum and C. rein-
hardtii N-glycan processing and as described for land plants
(Séveno et al., 2004; Zeleny et al., 2006), no sialic acid residues
were identified (Baïet et al., 2011; Mathieu-Rivet et al., 2013).
Sialic acids are terminal residues of O- and N-glycans that
are specifically involved in many biological functions in mam-
mals, such as the half-life of blood proteins and cell-cell adhe-
sion processes (Figure 1) (Varki, 1993; Gagneux and Varki,
1999).
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GLYCAN-REMODELING STRATEGIES IN MICROALGAE:
PERSPECTIVES
Differences in specificity of Golgi transferases and glycosidases
between eukaryotes give rise to glycosylation profiles that dif-
fer between mammals and other eukaryotic host cells used as
cell factories. As a consequence, glycansN-linked to recombinant
proteins produced in plants, yeast or even in animal cells differ
from the original therapeutic proteins. This may result in either a
decrease or absence of biological activity. Furthermore, unsuit-
able N-glycan structures introduced by the expression system
can induce immune responses in humans and generate adverse
reactions (Van Beers and Bardor, 2012), as reported for α(1,3)-
Gal epitope or Neu5Gc on therapeutic drugs (Chung et al.,
2008; Padler-Karavani et al., 2008). Similarly, plant synthesize
N-glycans carrying immunogenic core-xylose and core-α(1,3)-
fucose that may induce immune responses in human treated
with plant-made biopharmaceuticals (Bardor et al., 2003). In
consequence, whatever the expression system that is considered,
strategies have been carried out for the in vivo remodeling of
the protein N-glycans in order to obtain structures that meet
pharmaceutical requirements. For instance, knock-out of endoge-
nous genes involved in the transfer of core immunogenic epitopes
have been carried out to engineer oligosaccharides synthesized by
plant cell into human-compatible structures (Cox et al., 2006;
Schähs et al., 2007; Strasser et al., 2008). Furthermore, knock-
in methodologies based on the expression in the host cells of
mammalian enzyme have been developed to in vivo introduce
missing glycan sequences. In plants, these efforts resulted in the
production of plant-derived therapeutic proteins carrying N-
glycans similar to those found on human counterpart (Palacpac
et al., 1999; Bakker et al., 2001, 2006; Misaki et al., 2006; Paccalet
et al., 2007; Rouwendal et al., 2007; Castilho et al., 2008, 2010,
2013).
As reported in section Microalgae as Alternative Systems for
Production of Recombinant Proteins, C. reinhardtii and P. tri-
cornutum have been evaluated for their capacity to express
therapeutic proteins. The recent characterization of glycans N-
linked to their secreted proteins allows the design of strategies to
engineer their N-glycan pathways for the production of human-
compatible therapeutic proteins.
MICROALGAE FOR THE PRODUCTION OF LYSOSOMAL PROTEINS
Although complex N-glycans have been identified on proteins
secreted by C. reinhardtii and P. tricornutum, most abundant
oligosaccharides N-linked to proteins are oligomannosides rang-
ing from Man-2 to Man-5 in C. reinhardtii (Mathieu-Rivet
et al., 2013) and from Man-5 to Man-9 in P. tricornutum (Baïet
et al., 2011) (Figure 2). These N-linked glycans are appropri-
ate for the production of lysosomal therapeutics. For example,
glucocerebrosidase is a glycoprotein drug administered intra-
venously into patients suffering from Gaucher’s disease, a lyso-
somal storage disease. The effective targeting and internalization
of this therapeutic drug into macrophages depend on termi-
nal mannose residues of its N-glycans which are recognized by
macrophage cell surface mannose receptors (Van Patten et al.,
2007). For treatment, exogenous glucocerebrosidase is adminis-
tered intravenously into patients. The preparation of the current
glucocerebrosidase expressed in CHO cells (Cerezyme®) requires
in vitro post-purification and exoglycosidase digestions to expose
the trimannose core (Man3GlcNAc2, Man-3) using a combina-
tion of at least three enzymes namely sialidase, galactosidase
and N-acetylglucosaminidase (Figure 3A). These in vitro glyco-
engineering steps increase considerably the production costs
(Weinreb, 2008). Therefore, alternative expression systems that
are capable of producing mannose terminated N-glycans have
been developed as safe and cost effective production methods.
These include cultured carrot cells (Shaaltiel et al., 2007) and
A. thaliana cgl transgenic plants (He et al., 2012). However, the
analysis of the N-glycan profiles of these glucocerebrosidase bio-
similars revealedMan-5 with variable amount ofMan-6 toMan-9
structures (for example low amount of Man 6 to Man-8 on glu-
cocerebrosidase expressed in the Arabidopsis cgl mutant). The
presence of such structures required careful biosafety studies to
evaluate the possible binding to serum mannose binding lectin
(MBL) and immunogenicity (Van Patten et al., 2007; Grabowski
et al., 2014). The results described for C. reinhardtii (Mathieu-
Rivet et al., 2013) suggest that this greenmicroalgae could become
in the future an appropriate platform for the production of a
glucocerebrosidase bio-better which would naturally carry Man-
2 to Man-5 glycan structures without any in vitro trimming of
mannose residues (Figure 2).
MICROALGAE FOR THE PRODUCTION OF PROTEINS CARRYING
HUMAN-COMPATIBLE COMPLEX-TYPE N-GLYCANS
Based on data reported in section N-glycosylation Pathways
in Microalgae and Figure 2, the production in microalgae of
FIGURE 3 | Engineering of the N-linked glycans associated to
biopharmaceuticals. (A) Man-3 oligomannoside N-linked to the
recombinant glucocerebrosidase used for Enzyme Replacement Therapy in
patients suffering from Gaucher’s disease, a lysosomal storage disease.
(B) Trapping in the Golgi apparatus of intermediate GlcNAc-terminated
N-glycans by expression of a mammalian β(1,4)-galactosyltransferase
(GalT). Mannose Galactose N-acetylglucosamine.
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therapeutic proteins carrying human-like complex glycans will
require intensive remodeling of their glycan pathways. Although
no information is available on their immunogenicity, glycan epi-
topes identified on microalgae complex N-glycans will likely
induce adverse effects in humans. Removal of these putative
immunogenic glyco-epitopes, such as xylose and fucose residues,
as well as methyl groups on mannose residues, will first require
to identify gene encoding the corresponding glycosyltransferases
and methyltransferases and then to carry out appropriate knock-
out strategies such as RNA interference; artificial microRNA
which have already been developed in microalgae (Zhao et al.,
2009; Cerutti et al., 2011). If putative FuT genes have already been
identified because of their high homologies with plant α(1,3)-
FuT, the identification of sequences coding for xylosyltransferases
(XylT) will be more tricky. Only the β(1,2)-XylT family involved
in complex N-glycan biosynthesis in land plants have been bio-
chemically characterized so far (Strasser et al., 2000). To date, no
specific domain for XylT activity has been clearly identified and
so, search by homology for XylT in microalgae genomes failed to
clearly identify putative candidates.
As previously reported in land plants, “missing” residues
on glycan N-linked to therapeutic proteins can be introduced
by co-expression with appropriate glycosyltransferases. Results
regarding the complementation of CHO Lec1 mutant by P. tri-
cornutum GnT I (Baïet et al., 2011) showed that the targeting
of Golgi glycosyltransferases is conserved between microalgae
and higher eukaryotes. As a consequence, we can expect that
the expression in microalgae of heterologous glycosyltransferases
would allow the in vivo remodeling of their N-glycan pathways.
This heterologous expression of glycosyltransferases should be
particularly suitable for the remodeling of N-glycans in P. tri-
cornutum because this diatom possesses a functional GnT I
making its N-glycosylation pathway closer to the mammalian
one (Figures 1, 2). The terminal GlcNAc introduced by GnT
I constitute the starting point for the building of antennae in
mammalian complex N-glycans (Figure 1). We postulated that
in P. tricornutum this terminal GlcNAc is lost during the traf-
ficking of the glycoprotein by action of N-acetylglucosaminidases
(Figure 2). However, the expression of a mammalian β(1,4)-
galactosyltransferase in P. tricornutum would allow the trans-
fer in the Golgi apparatus of a terminal Gal on the terminal
GlcNAc, thus giving rise to a Galβ(1,4)GlcNAc extension that
will protect this N-acetylglucosamine residue introduced by GnT
I from degradation by N-acetylglucosaminidases downstream in
the secretory pathway (Figure 3B). In addition, this extension
corresponds to glycosidic motif found on some therapeutic pro-
teins such as IgG. This strategy based on the trapping of interme-
diate GlcNAc-terminated N-glycans has already been successfully
carried out in land plants (Bakker et al., 2001; Huether et al., 2005;
Vézina et al., 2009) and insect cells (Hollister et al., 1998).
SEARCH FOR MICROALGAE HAVING APPROPRIATE N-GLYCOSYLATION
PATHWAYS
As in vivo engineering of theN-glycosylation pathways in C. rein-
hardtii and P. tricornutum may represent a tricky work, explo-
ration for a microalga that exhibits a more appropriate protein
glycosylation has to be considered. A first overview of protein
N-glycosylation in various microalgae species can be draw on
the basis of public genomic databases. In addition to C. rein-
hardtii and P. tricornutum, more than 15 genomes from other
microalgae are now available (e.g., Thalassossira pseudonana;
Cyanidioschyzonmerolae;Ostreococcus tauri andOstreococcus luci-
marinus;Micromonas pusilla; Chlorella vulgaris; Coccomyxa subel-
lipsoidea; Nannochloropsis gaditana; Monoraphidium neglectum;
Table 2) (Ambrust et al., 2004; Misumi et al., 2005; Palenik et al.,
2007; Worden et al., 2009; Blanc et al., 2010, 2012; Radakovits
et al., 2012; Vieler et al., 2012; Bogen et al., 2013). Searches for
ALG genes and other sequences encoding proteins involved in
the ER protein quality control indicated that enzymes of the ER
machinery are predicted in all genomes suggesting that ER steps
of the N-glycan pathway are conserved over the microalgae phyla
as discussed recently in Levy-Ontman et al. (2014).With regard to
Golgi events, Table 2 summarizes and reports the genes predicted
to encode enzymes involved in the maturation of the N-glycans.
As observed forC. reinhardtii and P. tricornutum, α-mannosidases
(CAZy GH 47) and α(1,3)-fucosyltransferases (CAZy GT10) are
predicted in most microalgae genomes. In contrast, genes encod-
ing GnT I are not predicted in all genomes (Table 2; Baïet et al.,
2011). For instance, as for C. reinhardtii, no GnT I was found
in Volvox and Ostreococcus species whereas this key transferase is
predicted in most other microalgae, including haptophytes and
cryptophytes (Table 2; Baïet et al., 2011). As demonstrated in
C. reinhardtii and P. tricornutum, this indicates that the Golgi
maturation of protein N-linked glycans into complex oligosac-
charides could either occur through a GnT I-dependent pathway
or a GnT I-independent pathway in microalgae. In the context
of microalgae-made biopharmaceutical production, this feature
must be considered since the engineering ofmicroalgaeN-glycans
into human compatible oligosaccharides would be facilitated if a
GnT I-dependent machinery already exists in the strains selected
as an expression system.
CONCLUSIONS
In conclusion, it can be considered that remodeling N-glycans
as depicted in Figure 2 into human-compatible oligosaccharides
would be a difficult challenge to attend. However, recent produc-
tion in plants of therapeutic proteins carrying sialylated bianten-
nary N-glycans demonstrates that such a glycan engineering can
be achieved in a plant expression system (Castilho et al., 2013). It
should also be noticed that only a few microalgae species have
been investigated and so, data reported in this review should
be considered as a starting point regarding protein glycosyla-
tion mechanisms occurring in these unicellular organisms and
will serve as foundation for further glycobiology works. Efforts
have now to be carried out to get more information concern-
ing protein N-glycan structures and their pathways in different
phyla to identify microalgae species that are more appropri-
ate for glycan remodeling strategies into human-like structures.
This will also necessitate the characterization of the specificity of
Golgi glycosyltransferases, such as α-mannosidases and α(1,3)-
fucosyltransferases predicted in the microalgae genomes, to eval-
uate the efficiency in microalgae of heterologous expression of
glycosyltransferases as well as to identify genes encoding trans-
ferases (methyltransferases and xylosyltransferases) involved in
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Table 2 | Genes predicted in microalgae genomes encoding proteins involved in N-glycan Golgi maturation such as α-Man I, mannosyl
oligosaccharide alpha-1,2-mannosidase; GnT I, alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase; α(1,3)-FucT, core
α(1,3)-fucosyltransferase.
Microalgae α–Man I (K01230) GnT I (K00726) α(1,3)-FucT (K00753)
G
re
en
al
ga
e Chlamydomonas reinharditii XP_001700094.1 No XP_001695259.1
Volvox carteri f. nagariensis XP_002957696.1 No XP_002947231.1
Ostreococcus lucimarinus XP_001421581.1 No XP_001420919.1
XP_001420471.1
Ostreococcus tauri XP_003083553.1 No XP_003082568.1
Micromonas sp RCC299 XP_002505356.1
XP_002499658.1
XP_002507699.1
XP_002506141.1
XP_002509370.1
Micromonas pusilla XP_003058165.1
XP_003060259.1
XP_003056751.1 No
Coccomyxa subellipsoidea C-169 XP_005648743.1 XP_005642764.1 XP_005645422.1
XP_005645113.1
XP_005645114.1
XP_005646358.1
Chlorella variabilis NC64A XP_005852238.1 XP_005843911.1 XP_005848640.1
R
ed
al
ga
e Cyanidioschyzon merolae XP_005535714.1 No No
Galdieria sulphuraria NO XP_005709370.1 and
XP_005709369.1
XP_005708906.1
S
tr
am
en
op
ile Phaeodactylum tricornutum XP_002176357.1 XP_002182611.1 XP_002180610.1
XP_002180609.1
XP_002180883.1
Thalassiosira pseudonana XP_002289677.1
XP_002291430.1
XP_002289678.1
XP_002286885.1 XP_002290743.1
Fragilariopsis cylindrus JGI Protein Id:
168118
JGI Protein Id:
261302
JGI Protein ID: 189180 JGI Protein ID: 169403
Aureococcus anophagereffens EGB10338.1
EGB09525.1
EGB06148.1
EGB09718.1
AC236110.1
EGB04621.1
EGB04867.1
EGB09791.1
EGB12497.1
EGB10167.1
Nannochloropsis gaditana CCMP526 XP_005853502.1
XP_005853501.1
No No
H
ap
to
-p
hy
te Emiliania huxley XP_005786216.1
XP_005777157.1
XP_005762577.1
XP_005758261.1
EOD18227.1
XP_005771362.1
XP_005771219.1
XP_005769752.1
XP_005762959.1
XP_005788156.1
XP_005775869.1
C
ry
pt
o-
ph
yt
e Guillardia theta XP_005835818.1
XP_005827979.1
XP_005818934.1 XP_005818444.1
XP_005834963.1
XP_005839924.1
XP_005827855.1
XP_005835841.1
XP_005829578.1
Sequences were retrieved using the KEGG orthology or by search with the protein’s name (as defined in KEGG) in JGI, Phytozome or Genome at NCBI databanks.
In addition, search for candidates was carried out by BLASTP or TBLASTN using human alpha-1,2-mannosidase protein sequences, rabbit GnTI (P27115) and
Arabidopsis thaliana α(1,3)-FucT (Q9LJK1 and Q9FX97) as query sequences.
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the synthesis of putative immunogenic epitopes with the final goal
to selectively inactivate their expression.
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